Clinical Trial Update: Safety and Effectiveness of HIV-1 DNA Plasmid Vaccine and HIV-1 Recombinant Adenoviral Vector Vaccine in HIV-Uninfected, Circumcised Men and Male-to-Female (MTF) Transgender Persons Who Have Sex With Men [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating HIV-1 DNA plasmid vaccine and HIV-1 recombinant adenoviral vector vaccine in HIV-uninfected circumcised men and MTF transgende…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infections

Drugs mentioned

• HIV-1 DNA plasmid vaccine (HIV-1 DNA plasmid vaccine)
• HIV-1 recombinant adenoviral vector vaccine (HIV-1 recombinant adenoviral vector vaccine)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: HIV Infections | Phase 2 | Status: TERMINATED | Results posted: 2019-02-27